Related Experiment Video
Updated: May 11, 2026
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
A prospective comparison between cyclopentolate spray and drops in pediatric outpatients
Journal of Pediatric Ophthalmology and Strabismus
|May 28, 2013
Summary
Cyclopentolate 1% spray causes less distress in children 7 years or younger compared to drops. However, the spray does not achieve adequate cycloplegia for objective refraction in a significant number of young patients.
Area of Science:
- Ophthalmology
- Pediatric Eye Care
Background:
- Accurate refractive error assessment in children is crucial for timely intervention.
- Cyclopentolate is a commonly used cycloplegic agent, but its administration can cause distress.
Purpose of the Study:
- To compare the tolerability of cyclopentolate 1% spray versus drops in pediatric patients.
- To evaluate the efficacy of cyclopentolate 1% spray for achieving adequate cycloplegia for objective refraction.
Main Methods:
- Prospective study involving children 10 years or younger.
- Distress levels assessed via guardian questionnaires using a 1-10 Likert scale.
- Physician questionnaires evaluated cycloplegia adequacy and waiting times for spray administration.
Main Results:
- Children 7 years or younger reported significantly less distress with cyclopentolate spray (P < .005).
- No significant difference in distress was observed in children older than 7 years (P = .9719).
- Inadequate cycloplegia for objective refraction occurred in 13 of 77 children (16.9%) receiving the spray.
Conclusions:
- Cyclopentolate 1% spray offers improved tolerability over drops for younger children (≤7 years).
- The efficacy of cyclopentolate 1% spray for achieving adequate cycloplegia for objective refraction is insufficient in a notable percentage of pediatric patients.
Related Concept Videos
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...